Trump Urges GOP to Eliminate Senate Filibuster
In a dramatic political move, Donald Trump urges Republicans to eliminate Senate filibuster after midterm losses. Discover how this could reshape American politics.
Category : Search result: pharma losses
Trump on Election Losses: End Senate Filibuster Now
Former President Donald Trump reflects on Republican election setbacks in New York, Virginia, and New Jersey while accusing Democrats of shutdown tactics and pushing for Senate rule changes.
IndiGo's GIFT City Leasing to Cut Forex Losses & Expand Fleet
IndiGo CEO Pieter Elbers reveals revolutionary aircraft leasing plan through GIFT City to combat foreign exchange losses and accelerate fleet expansion while reducing dependency on foreign lessors.
Solara Pharma Q2 Loss: ₹10 Crore Amid Challenges
Solara Active Pharma Sciences faces challenging quarter with ₹10 crore net loss despite revenue growth. Discover the operational challenges and management's recovery strategy.
Sun Pharma Q2 Profit Rises 2.5% to ₹3,118 Crore
India's pharmaceutical giant Sun Pharma reports steady Q2 growth with 9% revenue increase while navigating US market challenges. Key insights from their latest earnings report.
Navin Fluorine Shares Surge 22% in 3 Sessions
Discover why Navin Fluorine International shares skyrocketed 22% in just three trading sessions. Expert analysis reveals the key drivers behind this chemical sector powerhouse's impressive rally and what investors should watch next.
Trump Blames Education System for Republican Election Losses
Former President Donald Trump attributes Republican electoral defeats to liberal education systems and 'Mamdani NYC,' claiming they're creating generations of anti-Republican voters.
Biden: Trump's absence cost Republicans elections
President Biden claims Republican losses in key local elections stem from Trump not being on the ballot, analyzing the impact of diminished MAGA voter turnout.
SoftBank Stock Crashes 14%, Loses $50B in 2 Days
SoftBank shares plummet over 14% as market cap evaporates by nearly $50 billion in two trading sessions. The dramatic fall follows disappointing earnings and growing investor concerns about the tech giant's portfolio companies.
Trump Explains Republican Election Losses: Two Key Reasons
Former President Donald Trump identifies lack of mail-in voting and poor candidate quality as primary reasons for Republican defeats in recent US mayoral and gubernatorial elections.
Q2 Results Today: Sun Pharma, Grasim, Britannia Earnings
Market eyes Wednesday's Q2 earnings bonanza as pharma giant Sun Pharma, Grasim Industries, and FMCG major Britannia declare results. Get complete analysis and investor expectations.
IndiGo Q2 Loss Widens to ₹2,582 Crore
India's largest airline IndiGo reports widened quarterly losses amid currency volatility and operational challenges. Discover how the weakening rupee impacted their financial performance.
IndiGo's Q2 Nightmare: ₹2,582 Crore Loss
India's largest carrier IndiGo reports massive quarterly loss as foreign exchange turbulence and rising costs ground profitability. Detailed analysis inside.
IndiGo Q2: Revenue Rises But Losses Widen on Forex Costs
India's largest airline IndiGo reports widened net loss despite 9.3% revenue growth as foreign exchange costs create major headwinds. Here's what investors need to know.
IndiGo Posts ₹2,582 Crore Q2 Loss on Forex Woes
IndiGo reports massive ₹2,582 crore Q2 loss due to foreign exchange impacts, while revenue climbs 9% year-over-year. Discover how cost pressures are challenging India's largest airline.
US Election 2025: Democrats Secure Major State Victories
Breaking analysis of 2025 US election outcomes: Democrats secure crucial victories in New York, New Jersey, Virginia, and California while Republicans struggle in key battleground states.
3 Hot Stocks: Grasim, Aurobindo Pharma, City Union Bank
Religare Broking's Ajit Mishra reveals 3 promising stocks for short-term gains. Discover technical analysis and price targets for Grasim, Aurobindo Pharma, and City Union Bank in this exclusive market insight.
Hot Stocks: Oil India, Aurobindo Pharma, Latent View Analysis
Get expert stock market insights from Jigar Patel of Anand Rathi as he reveals why Oil India, Aurobindo Pharma, and Latent View Analytics present compelling short-term opportunities for Indian investors.
Gujarat Farmers Face Crop Crisis From Unseasonal Rains
Unexpected heavy rainfall continues to batter Gujarat, causing significant damage to standing crops and raising concerns about agricultural losses and food security.
Katra Traders Face Ruin as Train Services Remain Dead
Shopkeepers and hotel owners in Katra report devastating losses as prolonged suspension of train services to the Vaishno Devi pilgrimage town continues to cripple local economy and tourism.
Urban Company Posts Losses Amid Major Expansion Push
Urban Company reveals significant financial losses as it doubles down on expansion strategy. Discover how the platform is investing in technology and new markets despite current challenges.
ECL reopens closed mines in coal revival drive
Eastern Coalfields revives closed mines under MDO model, targeting increased production and financial turnaround in India's coal sector revival.
Gujarat CM Orders Crop Damage Assessment in 3 Days
Gujarat Chief Minister issues urgent directive for rapid assessment of agricultural losses following unexpected rainfall, promising farmer support and compensation.
Putin: Zelensky Hiding Ukraine War Losses via Media Blackout
Russian President Vladimir Putin makes explosive allegations against Ukrainian leader Volodymyr Zelensky, accusing him of suppressing media freedom to conceal devastating battlefield casualties. Read the shocking revelations that are making global headlin
Health Biotech Expands Global Presence at CPhI Frankfurt
Indian biopharmaceutical leader Health Biotech Limited makes waves at CPhI Frankfurt 2025, showcasing innovative products and forging international partnerships to strengthen its global market position.
Niner Pharma Expands R&D with 125 New Peptide Molecules
Chandigarh-based Niner Pharma announces massive R&D expansion with 125 novel peptide molecules targeting wellness and cosmetic innovation, positioning India as global leader in peptide research.
Bengaluru family poison tragedy: 2 dead after real estate losses
A Bengaluru family's desperate act leaves two dead and two fighting for life after consuming poison, with police investigating massive real estate financial losses as the motive.
Swiggy Q2 Losses Widen to ₹1,617 Crore
Food delivery giant Swiggy reports widening losses amid intense competition with Blinkit and Zepto. Company plans cash reserve boost for Instamart expansion in quick commerce showdown.
Swiggy Q2: Revenue Soars 40% But Losses Widen
Swiggy's Q2 FY24 shows explosive 40% revenue growth to ₹2,730 crore, but net loss expands to ₹1,630 crore. Discover the 5 key factors every investor must know about the food delivery giant's financial health.
Cipla Shares Fall 4% After Q2 Results
Cipla's stock faced significant pressure after Q2 FY2025 results revealed margin pressures despite revenue growth. Discover the key factors behind the 4% decline and what analysts are saying about the pharmaceutical giant's future prospects.
Page 1 of 3